A Cohort of Patients With Chronic Pulmonary Disease
A Long-term, Prospective, Observational Cohort of Patients With Chronic Pulmonary Disease
1 other identifier
observational
100
1 country
1
Brief Summary
This is a longitudinal study of following chronic pulmonary disease patients to observe and predict the clinical outcomes of these patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 7, 2019
CompletedFirst Posted
Study publicly available on registry
August 9, 2019
CompletedStudy Start
First participant enrolled
August 22, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2021
CompletedOctober 22, 2019
October 1, 2019
2 years
August 7, 2019
October 21, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of acute exacerbations
The rate of exacerbations within 1 year of these patients will be tracked.
1 year
Secondary Outcomes (4)
Survival
1 year
Forced expiratory volume in 1 second
1 year
Health related quality of life: questionnaires
1 year
6-minute walk test
1 year
Study Arms (1)
CRD patients
Patients with chronic pulmonary disease like COPD, asthma, bronchiectasis, and etc.
Interventions
Recording the clinical, pathophysiology, and psychological parameters, to observe and predict the clinical outcomes of these patients.
Eligibility Criteria
This is a longitudinal study of following obstructive pulmonary disease patients from the outpatient clinic.
You may qualify if:
- Age 18-80, males and females
- Patients are diagnosed as the obstructive pulmonary disease according to the clinical practice.
- Willing to participate in the study.
- Being able to provide informed consent.
You may not qualify if:
- Subjects with severe heart failure, severe arrhythmias, unstable angina, and malignant comorbidities.
- Subjects with significantly impaired cognitive function and are unable to fulfill the study requirement (unable to provide informed consent)
- Subjects who participated in another trial within 30 days prior to the planned start of the study
- Subjects with cancer or have had cancer in the 5 years prior to study entry.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guangzhou Institute of Respiratory Disease
Guangzhou, Guangdong, 510000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Rongchang Chen, MD
The First Affiliated Hospital of Guangzhou Medical University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 7, 2019
First Posted
August 9, 2019
Study Start
August 22, 2019
Primary Completion
September 1, 2021
Study Completion
September 1, 2021
Last Updated
October 22, 2019
Record last verified: 2019-10